This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Brazilian subsidiaries of Siemens Healthcare, Baxter, others, settle information-exchange probe in healthcare market

By Ana Paula Candil ( September 21, 2022, 17:19 GMT | Insight) -- Brazilian subsidiaries of Siemens Healthcare, Edwards Lifesciences, Baxter International, PerkinElmer, Olympus Corporation and Stryker Corporation, as well as 35 individuals linked to them, have agreed to pay fines totaling 34.3 million reais ($6.62 million) to settle an investigation into the exchange of sensitive information regarding employees in the healthcare product, equipment and services market. Brazilian subsidiaries of Siemens Healthcare, Edwards Lifesciences, Baxter International, PerkinElmer, Olympus Corporation, and Stryker Corporation, as well as 35 individuals linked to them, have agreed to pay fines totaling 34.3 million reais ($6.62 million) to settle an investigation into the exchange of sensitive information regarding employees in the healthcare product, equipment and services market....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections